Max Biopharma, Inc. — SBIR/STTR Competitive Profile

Aggregate SBIR/STTR award history for Max Biopharma, Inc., built entirely from public federal award records. Free competitive intelligence — no login required.

Phase mix

Funding agencies

Awards by year

Places of performance

Firms like Max Biopharma, Inc.

See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.

Recent awards

AwardAgencyAmountProgramStart
1R44DK136405-01 Department of Health and Human Services $896,990 SBIR · Phase II 2023-05-01
1R43HL165998-01 Department of Health and Human Services $318,089 SBIR · Phase I 2022-08-10
1R43HL162245-01A1 Department of Health and Human Services $320,724 SBIR · Phase I 2022-05-23
1R44AR079335-01 Department of Health and Human Services $1,707,540 SBIR · Phase II 2021-09-01
1R43DK125139-01A1 Department of Health and Human Services $223,696 SBIR · Phase I 2020-08-21
9R44AG055374-02 Department of Health and Human Services $998,650 SBIR · Phase II 2016-09-15
2R44AR065148-02A1 Department of Health and Human Services $899,267 SBIR · Phase II 2016-03-17
1R43AR065148-01 Department of Health and Human Services $147,188 SBIR · Phase I
1R43AR065808-01A1 Department of Health and Human Services $149,342 SBIR · Phase I

Frequently asked questions

How many SBIR/STTR awards has Max Biopharma, Inc. won?

Max Biopharma, Inc. has won 9 SBIR/STTR awards worth $5,661,486 in the public federal award records SBIR Signal tracks, including 5 Phase I and 4 Phase II award(s).

Which agencies fund Max Biopharma, Inc.?

Max Biopharma, Inc.'s awards come from 1 agency on record; its top funder is Department of Health and Human Services.

What technology areas does Max Biopharma, Inc. work in?

Based on its award history, Max Biopharma, Inc. works in a range of technology areas.

How do I find firms similar to Max Biopharma, Inc.?

Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.